Neuronetics Profit Margin 2017-2019 | STIM
Current and historical gross margin, operating margin and net profit margin for Neuronetics (STIM) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Neuronetics net profit margin as of June 30, 2019 is -43.85%.
|Neuronetics Annual Profit Margins
|Neuronetics Quarterly Profit Margins
||Medical Instruments Manufacturing
Neuronetics, Inc. is a commercial-stage medical device company. It focused on designing, developing, and marketing products for patients who suffer from psychiatric disorders. NeuroStar Advanced Therapy System(R), is the transcranial magnetic stimulation treatment for depressive disorder. Neuronetics, Inc. is based in Malvern, United States.